2-溴-5-氯硝基苯 | 57381-37-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-5-氯硝基苯
• 中文别名: 2-溴-5-氯苯甲腈；2-溴-5-氯苯腈
• 英文名称: 2-bromo-5-chlorobenzonitrile
• 英文别名: 5-chloro-2-bromobenzonitrile
• CAS: 57381-37-0
• 化学式: C₇H₃BrClN
• 分子量: 216.465
• InChiKey: CTSHRMBLMKPDAG-UHFFFAOYSA-N

物化性质

• 熔点：
  138.8-139.2°C
• 沸点：
  271.6±25.0 °C(Predicted)
• 密度：
  1.74±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2926909090
• 危险性防范说明：
  P280
• 危险性描述：
  H302,H312,H332
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-5-chlorobenzonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-5-chlorobenzonitrile
CAS number: 57381-37-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H3BrClN
Molecular weight: 216.5

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-5-氯硝基苯 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 氧气 、 copper diacetate 、 caesium carbonate 、 三苯基膦 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 二甲基亚砜 为溶剂， 反应 27.0h， 生成 5-chloro-1,3-diphenyl-1H-indazole
  参考文献：
  名称：

  通过Cu（OAc）2催化的N–N键形成合成1 H-吲唑

  摘要：

  描述了一种容易合成的1 H-吲唑，其特征在于使用氧作为末端氧化剂，形成Cu（OAc）2催化的N–N键形成。易于获得的2-氨基苯甲腈与各种有机金属试剂的反应产生了邻氨基芳基NH酮亚胺。随后在氧气下在DMSO中形成Cu（OAc）2催化的N–N键，从而以良好或极好的收率提供了多种1 H-吲唑。

  DOI：

  10.1021/acs.orglett.6b00611
• 作为产物：
  描述：

  3-氯苯腈 在 1,3-二溴-5,5-二甲基海因 、 硫酸 、 三氟乙酸 作用下， 反应 6.0h， 以63%的产率得到2-溴-5-氯硝基苯
  参考文献：
  名称：

  有效合成高度官能化的4-芳基哌啶

  摘要：

  在该手稿中，公开了功能化的4-芳基哌啶的有效合成。讨论了形成关键的芳基-哌啶sp3碳-碳键的几种合成方法，包括通过酰基吡啶鎓离子与芳基格氏试剂反应形成相应的二氢吡啶而形成哌啶的可扩展路线。描述了通过二氢吡啶中间体获得BOC保护的哌啶的方法。

  DOI：

  10.1016/j.tet.2004.09.092

文献信息

• [EN] 4 -AMINO -7,8- DIHYDROPYRIMIDO [5, 4 - F] [1, 4] OXAZEPIN- 5 ( 6H) - ONE BASED DGAT1 INHIBITORS<br/>[FR] INHIBITEURS DE DGAT1 À BASE DE 4-AMINO-7,8-DIHYDROPYRIMIDO[5,4,F][1,4]OXAZÉPIN-5(6H)-ONE
  申请人：ASTRAZENECA AB

  公开号：WO2011121350A1

  公开（公告）日：2011-10-06

  DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro- drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.

  DGAT-1抑制剂化合物公式(I)，药用可接受的盐和前药，以及药物组合物、制造它们的方法以及它们在治疗例如糖尿病和肥胖症中的用途，其中，R1、R2、R3、R4、X2、q、Y1、Y2、n、Q和Z在描述中定义。
• Expeditious Synthesis of 2-Phenylquinazolin-4-amines via a Fe/Cu Relay-Catalyzed Domino Strategy
  作者：Feng-Cheng Jia、Zhi-Wen Zhou、Cheng Xu、Qun Cai、Deng-Kui Li、An-Xin Wu

  DOI：10.1021/acs.orglett.5b02020

  日期：2015.9.4

  efficient Fe/Cu relay-catalyzed domino protocol has been developed for the synthesis of 2-phenylquinazolin-4-amines from commercially available ortho-halogenated benzonitriles, aldehydes, and sodium azide. This elegant domino process involved consecutive iron-mediated [3 + 2] cycloaddition, copper-catalyzed SNAr, reduction, cyclization, oxidation, and copper-catalyzed denitrogenation sequences. The formed structure

  已经开发了一种高效的Fe / Cu中继催化多米诺协议，用于从可商购的邻卤代苄腈，醛和叠氮化钠合成2-苯基喹唑啉-4-胺。这种优美的多米诺骨牌工艺涉及连续的铁介导的[3 + 2]环加成，铜催化的S N Ar，还原，环化，氧化和铜催化的脱氮序列。形成的结构是药物和生物活性分子中的特权核心。
• [EN] DIHYDROBENZOXAZINE AND TETRAHYDROQUINOXALINE SODIUM CHANNEL INHIBITORS<br/>[FR] INHIBITEURS DES CANAUX SODIQUES DE TYPE DIHYDROBENZOXAZINE ET TÉTRAHYDROQUINOXALINE
  申请人：AMGEN INC

  公开号：WO2013122897A1

  公开（公告）日：2013-08-22

  The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, that are inhibitors of voltage-gated sodium channels, in particular Nav 1.7. The compounds are useful for the treatment of diseases treatable by inhibition of sodium channels such as pain disorders. Also provided are pharmaceutical compositions containing compounds of the present invention.

  本发明提供了式I的化合物或其药学上可接受的盐，这些化合物是电压门控钠通道的抑制剂，特别是Nav 1.7。这些化合物对于治疗可通过抑制钠通道治疗的疾病，如疼痛障碍，是有用的。还提供了含有本发明化合物的药物组合物。
• 一种化合物及其用途
  申请人：成都海博锐药业有限公司

  公开号：CN109575022B

  公开（公告）日：2021-09-21

  本发明提供了一种新化合物，该化合物对氧化还原酶吲哚胺2，3‑双加氧酶(IDO)有一定的抑制活性，或可用于治疗与之相关的疾病，包括癌症及免疫相关疾病的用途。
• 8-Substituted isoquinoline derivative and the use thereof
  申请人：Kaneko Shunsuke

  公开号：US20100261701A1

  公开（公告）日：2010-10-14

  The present invention relates to a compound represented by the following formula (1): wherein D 1 , A 1 , D 2 , R 1 , D 3 , and R 2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.

  本发明涉及一种由以下式（1）表示的化合物： 其中D1，A1，D2，R1，D3和R2分别具有与本说明书中定义的相同含义或其盐。由式（1）表示的化合物或其盐具有IKKβ抑制活性等，对于预防和/或治疗IKKβ相关疾病或症状等方面是有用的。